China Universal Asset Management Company’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Buy |
|
|||||
|
2025
Q1 | $82.9K | Sell |
|
|||||
|
2024
Q4 | $136K | Buy |
|
|||||
|
2024
Q3 | $419K | Buy |
|
|||||
|
2024
Q2 | $194K | Sell |
|
|||||
|
2024
Q1 | $458K | Buy |
|
|||||
|
2023
Q4 | $138K | Buy |
|
|||||
|
2023
Q3 | $24.2K | Buy |
|
|||||
|
2023
Q2 | $15.6K | Buy |
|
|||||
|
2023
Q1 | $15.9K | Buy |
|
|||||
|
2022
Q4 | $13.4K | Buy |
|
|||||
|
2022
Q3 | $9K | Buy |
|